SARS-CoV2 Infection
Showing 1 - 25 of 107
SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)
Recruiting
- SARS-CoV2 Infection
- General SARS-CoV-2 Communication
- Rural-Targeted SARS-CoV-2 Communication
-
Flint, MichiganFlint Journal Building
Oct 10, 2023
Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)
Not yet recruiting
- Post COVID-19 Condition, Unspecified
- +2 more
- Nirmatrelvir/ritonavir
- Placebo
- (no location specified)
May 9, 2023
SARS-CoV2 Infection Trial in Larissa (Hypertonic seawater solution)
Completed
- SARS-CoV2 Infection
- Hypertonic seawater solution
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Feb 15, 2023
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide
Recruiting
- Covid19
- +3 more
- Nitazoxanide and Ciclésonide
- +3 more
-
Bobo-Dioulasso, Burkina Faso
- +1 more
Jan 30, 2023
SARS-CoV2 Infection Trial in Renton (HDT-301)
Active, not recruiting
- SARS-CoV2 Infection
- HDT-301
-
Renton, WashingtonRainier Clinical Research
Jan 16, 2023
Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)
Recruiting
- Post Acute COVID-19 Syndrome
- +14 more
- stellate ganglion block with 0.5% bupivacaine
-
New York, New YorkHudson Medical
Jan 10, 2023
SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),
Active, not recruiting
- SARS-CoV2 Infection
- +3 more
- BNT162b2
- +5 more
-
Long Beach, California
- +34 more
Jan 10, 2023
SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among
Completed
- SARS-CoV2 Infection
- +3 more
- IM injection of vaccination (mRNA vaccination)
- IM injection of vaccination (vector based vaccination)
-
Hildesheim, Niedersachsen, GermanyHelios Hospital Hildesheim
Dec 29, 2022
SARS-CoV2 Infection, Covid19 Trial (Low-dose acetylsalicylic acid, Placebo)
Recruiting
- SARS-CoV2 Infection
- Covid19
- Low-dose acetylsalicylic acid
- Placebo
-
Maputo, Mozambique
- +3 more
Dec 16, 2022
SARS-CoV2 Infection Trial in Newark (Testing for SARS CoV2 Antigen and Antibody)
Active, not recruiting
- SARS-CoV2 Infection
- Testing for SARS CoV2 Antigen and Antibody
-
Newark, New JerseyRutgers School of Dental Medicine
Nov 5, 2022
SARS-CoV2 Infection Trial in Newark (Testing for SARS CoV2 RNA)
Completed
- SARS-CoV2 Infection
- Testing for SARS CoV2 RNA
-
Newark, New JerseyRutgers School of Dental Medicine
Nov 5, 2022
SARS-CoV2 Infection, COVID-19 Trial in United States (iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test)
Completed
- SARS-CoV2 Infection
- COVID-19
- iCura COVID-19 Antigen Rapid Home Test
- RT-PCR Test
-
DeLand, Florida
- +3 more
Oct 14, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
SARS-CoV2 Infection Trial in India (COVAXIN)
Completed
- SARS-CoV2 Infection
- COVAXIN
-
Visakhapatnam, Andhra Pradesh, India
- +6 more
Aug 17, 2022
SARS-CoV2 Infection, COVID-19 Trial in Long Beach, Miami Lakes, New York (IMM-BCP-01, Placebo)
Recruiting
- SARS-CoV2 Infection
- COVID-19
- IMM-BCP-01
- Placebo
-
Long Beach, California
- +2 more
Aug 11, 2022
SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood
Completed
- SARS-CoV2 Infection
-
Starkville, Mississippi
- +4 more
Aug 8, 2022
Lipids in SARS-CoV2 Infection - In Search of Atherogenic
Recruiting
- SARS-CoV2 Infection
- Blood sample of 30 ml
-
Dijon, FranceChu Dijon Bourgogne
Jul 25, 2022
COVID-19 Pandemic on Allogeneic Stem Cell Transplantation
Completed
- Allogeneic Stem Cell Transplantation
- +2 more
-
Vandoeuvre Les Nancy, Meurthe-et-Moselle, FranceCHRU of Nancy
Jul 19, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
COVID-19, SARS-CoV2 Infection Trial (Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies)
Not yet recruiting
- COVID-19
- SARS-CoV2 Infection
- Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies
- (no location specified)
Jul 14, 2022
MISC COVID-19 Study in Pediatric Population
Recruiting
- SARS-CoV2 Infection
- Multisystem Inflammatory Syndrome in Children
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Jul 7, 2022
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Covid19, SARS-CoV2 Infection, Coronavirus Disease 2019 Trial in France, Russian Federation, South Africa (Masitinib Mesylate,
Recruiting
- Covid19
- +2 more
- Masitinib Mesylate
- Placebo
-
Clermont-Ferrand, France
- +5 more
Jun 22, 2022
COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among
Active, not recruiting
- Covid19
- SARS-CoV2 Infection
- mRNA-1273
-
Tampa, FloridaMoffitt Cancer Center
Jun 20, 2022